• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 97 of 100
FinanceFDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
By Laura LorenzettiFebruary 4, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FeaturesIs it time for the FDA to consider cost when it comes to new drugs?
By Laura LorenzettiFebruary 4, 2015
Inside of a Gilead Sciences Lab
TechBigger drug discounts put question mark over Gilead’s stellar run
By Reuters and Coins2Day EditorsFebruary 4, 2015
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
FinanceHow to save on your prescription meds (yep, there’s an app for that)
By Jean ChatzkyFebruary 3, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Key Speakers At Osons La France Economic Summit
LeadershipFire in haste, repent at leisure: Sanofi wonders why it can’t find a new CEO
By ReutersJanuary 30, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FeaturesPfizer’s outlook disappoints as it struggles with patent expirations
By Laura LorenzettiJanuary 27, 2015
FeaturesRegeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Negatively-stained Hong Kong Flu Virus
FeaturesOne shot to cure them all: The quest for the universal flu shot
By Erika FryJanuary 21, 2015
FeaturesDetroit auto show and Obama on cybersecurity — 5 things to know today
By Laura LorenzettiJanuary 12, 2015
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
EyebrowShire switches from target to predator with $5.2 billion NPS buy
By Geoffrey SmithJanuary 12, 2015
TechA powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
Flu Outbreak Continues In Bay Area
RetailIt’s a bad flu season, but that’s good news for Walgreen
By Laura LorenzettiJanuary 6, 2015
Picture taken on January 15, 2012 in Lil
FeaturesThe U.S. has a drug shortage — and people are dying
By Mark KobaJanuary 6, 2015
EyebrowJ&J starts clinical trials of Ebola drug
By ReutersJanuary 6, 2015
1...
  • 95
  • 96
  • 97
  • 98
  • 99
100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’An image of a popular article
By Eva RoytburgFebruary 2, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.